Charlotte Morris
Has grant
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Open
Identifying, understanding and addressing socio-economic inequalities in the quality and safety of primary care for people with dementia
Open Date: 2025-01-31
Close Date: 2028-01-30
Grant: Close
NIHR In-Practice Fellowship 2021
Open Date: 2021-10-01
Close Date: 2023-09-30
Articles (12)
Background Locum doctors are vital for maintaining healthcare provision, especially in general practice. However, their levels of use, role, and impact remain relatively understudied and official statistics cannot be compared between UK countries. Aim To explore locum use more comprehensively in the UK, over time and across geographies. Design and setting A retrospective cohort study using the Clinical Practice Research Datalink (CPRD) GOLD from April 2010 to March 2022, analysing consultations across UK general practices. Method Consultation types were categorised by GP type (locum versus permanent). Multilevel mixed-effects logistic regressions modelled the association between locum consultations and patient and practice characteristics. Results Between 2010 and 2022, 914 UK general practices contributed to the dataset. UK locums provided more care than previously estimated, with a 2019 (pre-COVID-19 pandemic) mean of 14.9% (standard deviation 20.7) and median of 7.5% (interquartile range 2.3–17.5) of all consultations, indicating substantial variation. Over time, the use of locums in the UK remained relatively stable, but this masks different trends within the UK. The study found that use in England is increasing, in Scotland and Northern Ireland decreasing, and in Wales is flat. Regression analysis found that variation in locum use was largely unexplained by patient and practice characteristics. Conclusion This study indicates higher use of locums across the UK than available NHS statistics would suggest. These differences are probably because of alternative ways of measuring GP activity (consultations versus hours worked). Regional and country differences highlight diverse workforce challenges where local solutions may be needed. These findings contribute to understanding NHS workforce dynamics and may help inform strategies for primary care service delivery.
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Background: The increasing prevalence of dementia is expanding the role of primary care in its management. However, inequities exist in primary care for people with dementia, particularly with socioeconomic status. Individuals from socio-economically disadvantaged areas are underrepresented in research on this topic. Aim: To explore primary care experiences of people with dementia and their carers from socio-economically disadvantaged areas. Design and Setting: Qualitative interviews with people with dementia and their carers recruited from Index of Multiple Deprivation (IMD) quintile 1 or 2 postcodes. Method: We undertook 20 semi-structured interviews. Participants were purposively sampled by postcode via the Join Dementia Research Database. Participants were aged >18 years, with any type of dementia or were a carer for someone with dementia. Data were analysed using reflexive thematic analysis. Results: We identified four interrelated themes. These were: maintaining identity amidst impending loss, the paradox of healthcare support dropping away as needs increased, navigating the complex primary healthcare system, and uncertainty about where dementia healthcare sits within general practice. Views about the impact of socio-economic disadvantage varied. Some participants felt local resources, or individual social capital affected healthcare they received. Conclusions: Changes in primary care, including proactive contact, clearer communication of dementia-related care and consistent relationships could improve patient experience. Clarifying primary care's role in dementia management is essential, especially with proposed shifts towards primary care-led post-diagnostic support. Further work is needed to establish if these experiences are described by people with dementia across all social-strata or are specific to areas of socio-economic disadvantage.
Year:
2026
Year:
2026
Objectives To examine trends of opioid use, focusing on long-term opioid therapy (L-TOT) and its discontinuation among people with chronic non-cancer pain (CNCP). Design and setting Retrospective cohort study using UK Clinical Practice Research Datalink Aurum data. Population Incident opioid users (no opioid use in the prior year) with CNCP between 01/01/2009–31/12/2019. Among them, we identified L-TOT users (≥3 opioid prescriptions within 90 days, or total ≥90 supply days within the first year, excluding the initial 30 days) and L-TOT discontinuers (no opioid use for ≥180 days following a L-TOT). Main outcome measures Yearly rates of incident opioid users (over CPRD-registered patients), L-TOT users (over incident opioid users), and L-TOT discontinuers (over L-TOT users) were calculated. Annual counts of each group were fitted using segmented negative binomial regression models with an offset considering their corresponding denominators from 2009 to 2019, excluding 2014 due to policy changes in that year. Results Among 2,839,161 incident opioid users, 11.4% (n = 324,877) transitioned into L-TOT users within one year, of which 4.8% (n = 15,484) discontinued. Between 2009–2013, rates of L-TOT users significantly declined by 2.6% (incidence rate ratio: 0.974; 95% confidence interval: 0.971 to 0.978) per annum, followed by a significant step change in 2015 (1.026, 1.009 to1.044), and a significant annual increase of 2.4% (1.024, 1.019 to 1.029) from 2015 to 2019, compared to the 2009–2013 trend. The annual rates of L-TOT discontinuers remained stable from 2009 to 2013 (0.987, 0.971 to 1.002), followed by a non-significant step change (0.990, 0.916 to 1.070) in 2015, and a significant decrease in slope by 2.6% (0.974, 0.951 to 0.998) per annum during 2015–2019, relative to 2009–2013. Conclusions L-TOT has plateaued since 2015, accompanied with an accelerated decrease in discontinuation rates, suggesting ongoing reliance on opioids for CNCP management, despite increased awareness regarding L-TOT associated risks. This is likely due to the limited availability of other effective pharmacological options and non-pharmacological alternatives, and challenges in their accessibility.
Year:
2025
Introduction International guidelines make recommendations for the delivery of safe, high‐quality primary care for people with dementia including prescribing, personalised care planning and regular holistic reviews. It is unclear how the quality and safety of this healthcare varies with socio‐economic factors. Objective This scoping review aimed to understand the depth and breadth of existing evidence exploring socio‐economic variation in the quality and safety of primary care for people with dementia. Methods Prescribing and care planning indicators of high‐quality, safe primary care were defined from guidance. Composite and proxy markers of socio‐economic status (SES) were defined. EMBASE, MEDLINE, PsychInfo, The Cochrane Database of Systematic Reviews, worldcat.org and clinicaltrial.gov databases were searched. Studies in English, on human participants from 2006 onwards were eligible. Narrative synthesis was conducted. Studies explored how one or more selected indicators (anti‐dementia medication and anti‐psychotic prescribing, potentially inappropriate prescribing (PIP), medication review, dementia review or care planning) varied with a recognised marker of SES in people with dementia. Results Searches identified 1980 studies after removing duplicates. 385 full texts were reviewed, with 53 eligible for inclusion (51 quantitative, 2 reviews). Most identified studies explored prescribing processes (50 quantitative, 2 reviews), with 2 exploring annual review. There was evidence of substantial disparity in quality and safety indicators in studies exploring prescribing; 20/29 (69%) of studies exploring anti‐dementia medication prescribing found those with markers of lower SES were significantly less likely to receive these. 16/28 studies exploring PIP/Anti‐psychotics found significant disparities in safe prescribing for those with markers of lower SES. Neither study exploring annual reviews found any significant differences across SES. Conclusion We found evidence of disparity in the quality and safety of post‐diagnostic primary care for people with dementia based on SES, particularly for a range of prescribing indicators. Further work exploring inequalities in care planning and reviews for people with dementia is needed to understand existing inequalities in the quality and safety of primary care for people with dementia.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (10)
thomas allen
The University of Manchester
Kieran Walshe
The University of Manchester
Rosa Parisi
Dean's Prize Research Fellow
The University of Manchester
Darren Ashcroft
Professor
The University of Manchester
Tom Blakeman
The University of Manchester
Yun-Ting Huang
The University of Manchester
Evangelos Kontopantelis
The University of Manchester
Salwa S Zghebi
The University of Manchester
Pearl Mok
The University of Manchester
Jung Yin Tsang
The University of Manchester
Make your next move.
Prepare your application
Review drafts before you send them.